NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT00580320 2016-08-18Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaVirginia Commonwealth UniversityPhase 1 Completed17 enrolled